HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
COVID-19 Vaccine Development
  • Biopharmaceutical Development on COVID:19

COVID-19 vaccine development has facilitated through unparalleled collaboration in the pharmaceutical industry and between governments.  The geographic distribution of COVID-19 vaccine development puts North American entities having about 40% of the activity compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa

The safety requirements for COVID-19 vaccines are the same as for any other vaccine and will not be lowered in the context of the pandemic. After development, the vaccines will continue to be carefully monitored for safety and effectiveness

 

Committee Members
Speaker at Pharma Conferences - Saad Tayyab

Saad Tayyab

UCSI University, Malaysia
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Pharma Conferences - Marino Nebuloni

Marino Nebuloni

University of Insubria, Italy
PDDS 2025 Speakers
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Pharma Conferences - Marino Nebuloni

Marino Nebuloni

University of Insubria, Italy
Speaker at Pharma Conferences - Saad Tayyab

Saad Tayyab

UCSI University, Malaysia

Submit your abstract Today

Watsapp